Next Article in Journal
Artificial Intelligence in Laryngeal Endoscopy: Systematic Review and Meta-Analysis
Previous Article in Journal
Rapid Molecular Diagnosis of Genetically Inherited Neuromuscular Disorders Using Next-Generation Sequencing Technologies
 
Search for Articles:
Title / Keyword
Author / Affiliation
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
Journals
JCM
Volume 11
Issue 10
10.3390/jcm11102749
jcm-logo
Submit to this Journal Review for this Journal Edit a Special Issue
► Article Menu

Article Menu

share announcement question_answer thumb_up
...
textsms
...
Article

A Non-Invasive Neonatal Signature Predicts Later Development of Atopic Diseases

by
Youssouf Sereme
1,2,
Moïse Michel
1,2,3,
Soraya Mezouar
1,2,
Cheick Oumar Guindo
1,2,
Lanceï Kaba
1,4,
Ghiles Grine
1,2,5,
Thibault Mura
6,7,
Jean-Louis Mège
1,2,
Tu Anh Tran
8,9,10,
Pierre Corbeau
3,10,11,*,†,
Anne Filleron
8,9,10,*,† and
Joana Vitte
1,2,10,12,*,†
1
IHU Méditerranée Infection, 13005 Marseille, France
2
IRD, APHM, MEPHI, Aix-Marseille Université, 13284 Marseille, France
3
Immunology Department, University Hospital Nîmes, 30900 Nîmes, France
4
IRD, AP-HM, SSA, VITROME, Aix-Marseille Université, 13284 Marseille, France
5
UFR Odontologie, Aix-Marseille Université, 13284 Marseille, France
6
INSERM, University of Montpellier, U1061, Neuropsychiatry: Epidemiological and Clinical Research, 34093 Montpellier, France
7
Laboratoire de Biostatistique, Epidémiologie Clinique, Santé Publique Innovation et Méthodologie (BESPIM), Groupe Hospitalier Caremeau, CHU de Nîmes, Nîmes University Hospital, 30900 Nîmes, France
8
Paediatrics Department, University Hospital Nîmes, 30900 Nîmes, France
9
INSERM U1183, Institute for Regenerative Medicine & Biotherapy, 34295 Montpellier, France
10
Faculty de Medicine, Montpellier University, 34000 Montpellier, France
11
CNRS UMR 9002, Institute of Human Genetics, 34090 Montpellier, France
12
IDESP, INSERM UMR UA11, Institut Desbrest d’Epidemiologie et de Santé Publique (IDESP) Campus Sante, 34093 Montpellier, France
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Academic Editor: José Joaquín Cerón
J. Clin. Med. 2022, 11(10), 2749; https://doi.org/10.3390/jcm11102749
Received: 19 March 2022 / Revised: 9 May 2022 / Accepted: 10 May 2022 / Published: 12 May 2022
(This article belongs to the Topic Proteins in Health and Diseases: New Knowledge and Practical Applications)
View Full-Text Download PDF
Browse Figures
Review Reports

Abstract

Background: Preterm birth is a major cause of morbidity and mortality in infants and children. Non-invasive methods for screening the neonatal immune status are lacking. Archaea, a prokaryotic life domain, comprise methanogenic species that are part of the neonatal human microbiota and contribute to early immune imprinting. However, they have not yet been characterized in preterm neonates. Objective: To characterize the gut immunological and methanogenic Archaeal (MA) signature in preterm neonates, using the presence or absence of atopic conditions at the age of one year as a clinical endpoint. Methods: Meconium and stool were collected from preterm neonates and used to develop a standardized stool preparation method for the assessment of mediators and cytokines and characterize the qPCR kinetics of gut MA. Analysis addressed the relationship between immunological biomarkers, Archaea abundance, and atopic disease at age one. Results: Immunoglobulin E, tryptase, calprotectin, EDN, cytokines, and MA were detectable in the meconium and later samples. Atopic conditions at age of one year were positively associated with neonatal EDN, IL-1β, IL-10, IL-6, and MA abundance. The latter was negatively associated with neonatal EDN, IL-1β, and IL-6. Conclusions: We report a non-invasive method for establishing a gut immunological and Archaeal signature in preterm neonates, predictive of atopic diseases at the age of one year. View Full-Text
Keywords: preterm birth; fecal mediator and cytokine; methanogenic Archaea; allergy; atopy preterm birth; fecal mediator and cytokine; methanogenic Archaea; allergy; atopy
►▼ Show Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Supplementary Material

SciFeed

Share and Cite

MDPI and ACS Style

Sereme, Y.; Michel, M.; Mezouar, S.; Guindo, C.O.; Kaba, L.; Grine, G.; Mura, T.; Mège, J.-L.; Tran, T.A.; Corbeau, P.; Filleron, A.; Vitte, J. A Non-Invasive Neonatal Signature Predicts Later Development of Atopic Diseases. J. Clin. Med. 2022, 11, 2749. https://doi.org/10.3390/jcm11102749

AMA Style

Sereme Y, Michel M, Mezouar S, Guindo CO, Kaba L, Grine G, Mura T, Mège J-L, Tran TA, Corbeau P, Filleron A, Vitte J. A Non-Invasive Neonatal Signature Predicts Later Development of Atopic Diseases. Journal of Clinical Medicine. 2022; 11(10):2749. https://doi.org/10.3390/jcm11102749

Chicago/Turabian Style

Sereme, Youssouf, Moïse Michel, Soraya Mezouar, Cheick O. Guindo, Lanceï Kaba, Ghiles Grine, Thibault Mura, Jean-Louis Mège, Tu A. Tran, Pierre Corbeau, Anne Filleron, and Joana Vitte. 2022. "A Non-Invasive Neonatal Signature Predicts Later Development of Atopic Diseases" Journal of Clinical Medicine 11, no. 10: 2749. https://doi.org/10.3390/jcm11102749

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Map by Country/Region

1
Back to TopTop